date:Apr 27, 2012
consult with the agency before taking their products to market. Such consultation can help FDA experts address questions related to the safety or other attributes of nanotechnology products, or answer questions about their regulatory status.
Strong science is critical to FDAs ongoing review of the products it regulates. FDA is investing in an FDA-wide nanotechnology regulatory science program to further enhance FDAs scientific capabilities, including developing necessary data and tools to ident